These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2282970)

  • 21. Selection of enhanced cefotaxime resistance in Enterobacter spp.
    Hopkins JM; Towner KJ; Slack RC; Harper PB; Simpson IN
    J Antimicrob Chemother; 1987 Oct; 20(4):489-96. PubMed ID: 3500163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of spontaneous Enterobacter cloacae mutants with temperature-conditional derepression of type I beta-lactamase synthesis.
    Curtis NA; East SJ; Cornford RJ; Walker LA
    J Antimicrob Chemother; 1987 Apr; 19(4):417-27. PubMed ID: 3495528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical antibacterial activity of cefmenoxime against Proteus vulgaris.
    Ikeda Y; Nishino T; Tanino T
    Antimicrob Agents Chemother; 1987 Jun; 31(6):865-9. PubMed ID: 3304155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inducer activity of beta-lactam antibiotics for the beta-lactamases of Proteus rettgeri and Proteus vulgaris.
    Yotsuji A; Minami S; Araki Y; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1982 Nov; 35(11):1590-3. PubMed ID: 6761329
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanisms and clinical relevance of antagonism between beta-lactam antibiotics.
    Bergogne-Berezin E
    Chemioterapia; 1985 Feb; 4(1):47-52. PubMed ID: 3872724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in induction of chromosomal beta-lactamase expression in strains of Enterobacter cloacae.
    Stoorvogel J; van Gestel MH; Ketelaar-van Gaalen PA; Mouton RP; van de Klundert JA
    Chemotherapy; 1991; 37(3):175-85. PubMed ID: 1889305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
    Beckwith DG; Jahre JA
    J Clin Microbiol; 1980 Oct; 12(4):517-20. PubMed ID: 6968320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of chromatofocusing for separation of beta-lactamases. V. Inducible chromosomally mediated beta-lactamase of the Enterobacter cloacae 53 strain.
    Gál S; Frommer-Filep M; Toth-Martinez BL; Hernádi FJ; Kiss L
    J Chromatogr; 1985 Sep; 333(1):239-43. PubMed ID: 3877734
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of beta-lactamase induction in Enterobacter cloacae.
    Gootz TD; Sanders CC
    Antimicrob Agents Chemother; 1983 Jan; 23(1):91-7. PubMed ID: 6402977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonspecific induction of beta-lactamase in Enterobacter cloacae.
    Cullmann W; Dick W; Dalhoff A
    J Infect Dis; 1983 Oct; 148(4):765. PubMed ID: 6605393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.
    Ohno A; Ishii Y; Ma L; Yamaguchi K
    J Clin Microbiol; 2000 Feb; 38(2):677-81. PubMed ID: 10655366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic in vitro studies of antibacterial effects of the combination of new penicillins and cefalosporins against Proteus vulgaris.
    Dalhoff A; Gehl AE; Lode H
    Chemotherapy; 1982; 28(5):381-9. PubMed ID: 6754281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
    Minami S; Araki H; Watanabe Y; Yasuda T; Takai A; Saikawa I; Mitsuhashi S
    Antimicrob Agents Chemother; 1986 Feb; 29(2):376-8. PubMed ID: 3521482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of casein derivatives on glycine enhancement of beta-lactamase production in Enterobacter cloacae ATCC.13047.
    Gatus BJ; Bell SM; Jimenez AS
    Pathology; 1986 Oct; 18(4):379-81. PubMed ID: 3493468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and antibacterial efficacy in vivo of beta-lactam combinations against Proteus vulgaris.
    Dalhoff A; Gehl AE; Gau W; Lode H
    Chemotherapy; 1982; 28(6):444-53. PubMed ID: 6761080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of mezlocillin and cefoxitin against Proteus morganii in the granuloma pouch model.
    Dalhoff A
    Eur J Clin Microbiol; 1982 Aug; 1(4):243-7. PubMed ID: 6217067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and properties of beta-lactamase from Proteus vulgaris.
    Tajima M; Takenouchi Y; Ohya S; Sugawara S
    Microbiol Immunol; 1982; 26(6):531-4. PubMed ID: 6752667
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of urease formation in certain aerobic bacteria.
    Kaltwasser H; Krämer J; Conger WR
    Arch Mikrobiol; 1972; 81(2):178-96. PubMed ID: 4622647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.